These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37278090)

  • 1. Understanding the Mechanism and Extent of Transplacental Transfer of (-)-∆
    Kumar AR; Sheikh ED; Monson JW; Ligon SE; Talley RL; Dornisch EM; Howitz KJ; Damicis JR; Ieronimakis N; Unadkat JD
    Clin Pharmacol Ther; 2023 Aug; 114(2):446-458. PubMed ID: 37278090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and Fetal Exposure to (-)-Δ
    Chen X; Unadkat JD; Mao Q
    Drug Metab Dispos; 2023 Mar; 51(3):269-275. PubMed ID: 36446608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2).
    Chen X; Unadkat JD; Mao Q
    Drug Metab Dispos; 2021 Oct; 49(10):910-918. PubMed ID: 34326138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
    Peng J; Ladumor MK; Unadkat JD
    Drug Metab Dispos; 2022 May; 50(5):613-623. PubMed ID: 35149540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.
    Vinot C; Gavard L; Tréluyer JM; Manceau S; Courbon E; Scherrmann JM; Declèves X; Duro D; Peytavin G; Mandelbrot L; Giraud C
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1415-20. PubMed ID: 23295922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Prediction of Fetal Exposure to Dual BCRP/P-gp Drug Substrates Using the Efflux Ratio-Relative Expression Factor Approach and PBPK M&S.
    Balhara A; Yin M; Unadkat JD
    Clin Pharmacol Ther; 2024 May; 115(5):1044-1053. PubMed ID: 38124355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
    Han LW; Gao C; Mao Q
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the role of nucleoside transporters, P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in the placental transport of entecavir using in vitro, ex vivo, and in situ methods.
    Cerveny L; Karbanova S; Karahoda R; Horackova H; Jiraskova L; Ali MNH; Staud F
    Toxicol Appl Pharmacol; 2023 Mar; 463():116427. PubMed ID: 36801311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus.
    Sudhakaran S; Rayner CR; Li J; Kong DC; Gude NM; Nation RL
    Br J Clin Pharmacol; 2008 May; 65(5):667-73. PubMed ID: 18093255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
    Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
    J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplacental transfer of nitrosodimethylamine in perfused human placenta.
    Annola K; Heikkinen AT; Partanen H; Woodhouse H; Segerbäck D; Vähäkangas K
    Placenta; 2009 Mar; 30(3):277-83. PubMed ID: 19215982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB1 expression is increased in human first trimester placenta from pregnant women classified as overweight or obese.
    Justesen S; Bilde K; Olesen RH; Pedersen LH; Ernst E; Larsen A
    Sci Rep; 2023 Mar; 13(1):5175. PubMed ID: 36997557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental Pharmacokinetic Model of Digoxin Based on Ex Vivo Human Placental Perfusion Study.
    Kurosawa K; Noguchi S; Nishimura T; Tomi M; Chiba K
    Drug Metab Dispos; 2022 Mar; 50(3):287-298. PubMed ID: 34903589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and Simulation.
    Anoshchenko O; Storelli F; Unadkat JD
    Drug Metab Dispos; 2021 Oct; 49(10):919-928. PubMed ID: 34426410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics.
    Tupova L; Ceckova M; Ambrus C; Sorf A; Ptackova Z; Gaborik Z; Staud F
    Drug Metab Dispos; 2019 Sep; 47(9):954-960. PubMed ID: 31266750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.
    Feinshtein V; Erez O; Ben-Zvi Z; Eshkoli T; Sheizaf B; Sheiner E; Holcberg G
    Am J Obstet Gynecol; 2013 Dec; 209(6):573.e1-573.e15. PubMed ID: 23933222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is bisphenol S a safer alternative to bisphenol A in terms of potential fetal exposure ? Placental transfer across the perfused human placenta.
    Grandin FC; Lacroix MZ; Gayrard V; Viguié C; Mila H; de Place A; Vayssière C; Morin M; Corbett J; Gayrard C; Gely CA; Toutain PL; Picard-Hagen N
    Chemosphere; 2019 Apr; 221():471-478. PubMed ID: 30654261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice.
    Spiro AS; Wong A; Boucher AA; Arnold JC
    PLoS One; 2012; 7(4):e35937. PubMed ID: 22536451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism.
    Immonen E; Kummu M; Petsalo A; Pihlaja T; Mathiesen L; Nielsen JK; Knudsen LE; Vähäkangas K; Myllynen P
    Placenta; 2010 Jul; 31(7):641-8. PubMed ID: 20570348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
    Biali ME; Auvity S; Cisternino S; Smirnova M; Hacker M; Zeitlinger M; Mairinger S; Tournier N; Bauer M; Langer O
    Mol Pharm; 2023 Nov; 20(11):5877-5887. PubMed ID: 37883694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.